Sharmila Joshi, Head of Equity of Peerless Securities told CNBC-TV18, “I expect more weakness in Divis Laboratories. Overall there is a sense that there seems to be a bit of a profit booking coming in the pharma space and if you report slightly average or bad numbers then that profit booking could deepen further. So we have seen a good rally and may be another 3-4 percent of downside is what we can look at.”
Divis Laboratories touched its 52-week high Rs 1,233 and 52-week low Rs 929 on 30 November, 2012 and 04 June, 2012, respectively. Currently, it is trading 18.29 percent below its 52-week high and 8.45 percent above its 52-week low. Market capitalisation stands at Rs 13,372.98 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
